OptiBiotix Health (LON:OPTI) Stock Price Up 13.3% – Still a Buy?

OptiBiotix Health Plc (LON:OPTI) shares traded up 13.3% on Thursday . The stock traded as high as GBX 6.74 and last traded at GBX 6.74. 676,800 shares changed hands during trading, an increase of 93% from the average session volume of 350,658 shares. The stock had previously closed at GBX 5.95.

OptiBiotix Health Stock Performance

The stock has a 50-day simple moving average of GBX 5.79 and a two-hundred day simple moving average of GBX 5.73. The firm has a market cap of £6.96 million, a PE ratio of -1.76 and a beta of 1.82.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.